Colleyville, TX, September 05, 2009 --(PR.com
)-- "In a historically difficult environment for raising capital, we are appreciative of the confidence that investors have placed in Heart Test Labs and its Management Team. We also want to thank our Financial Advisor, Neidiger, Tucker, Bruner Inc., a Denver-based Investment Banking Firm, for their competent support and Counsel." said Drew Diaz, CEO of Heart Test Laboratories.
The 1.8 Million in privately raised capital will assist Heart Test Labs team with their ongoing research, product development, and worldwide delivery of the MyoVista Heart Test System to health care markets.
“The Primary Care Physician is the first line of detection in the identification of silent heart disease, and we are committed to developing new technologies to support that goal”. Mr. Diaz further stated, "It is our intent to identify those patients that should be immediately sent to their Cardiologist for further assessment. The MyoVista provides an inexpensive, simple, non-invasive tool for Primary Care Physicians. As a company, we believe that such non-invasive tools will improve the quality of global health care. We are dedicated to providing solutions to this endeavor.”
Interested physicians, hospital administrators, and investors are invited to visit the Heart Test Laboratories Web Site at www.HeartTestLabs.com for more information, or contact Drew Diaz, CEO at 1-817-307-4848, or Malcolm McGuire, Consultant and Investor Liaison at 1-719-636-293.